Stockreport

NovaBay Pharmaceuticals Reports 2019 Second Quarter Net Sales of $1.8 Million

NovaBay Pharmaceuticals, Inc.  (NBY) 
NASDAQ:AMEX Investor Relations: novabay.com/investors
PDF Company to hold second quarter 2019 conference call on August 8 EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmac [Read more]